FARALLON CAPITAL MANAGEMENT LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 101 filers reported holding CARA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$401,513
-71.6%
1,556,2510.0%0.00%
-66.7%
Q1 2024$1,416,188
+22.5%
1,556,2510.0%0.01%
+20.0%
Q4 2023$1,156,294
-58.7%
1,556,251
-6.6%
0.01%
-61.5%
Q3 2023$2,799,873
-40.6%
1,666,5910.0%0.01%
-45.8%
Q2 2023$4,716,453
-51.9%
1,666,591
-16.5%
0.02%
-55.6%
Q1 2023$9,797,267
-56.0%
1,995,370
-3.8%
0.05%
-59.1%
Q4 2022$22,276,908
-4.8%
2,074,200
-17.0%
0.13%
+2.3%
Q3 2022$23,400,000
+2.5%
2,500,0000.0%0.13%
+4.0%
Q2 2022$22,825,000
-24.9%
2,500,0000.0%0.12%
-15.6%
Q1 2022$30,375,000
+24.7%
2,500,000
+25.0%
0.15%
+20.5%
Q4 2021$24,360,000
-21.2%
2,000,0000.0%0.12%
-15.3%
Q3 2021$30,900,000
+8.3%
2,000,0000.0%0.14%
+23.1%
Q2 2021$28,540,000
-46.7%
2,000,000
-18.9%
0.12%
-56.0%
Q1 2021$53,515,000
+43.5%
2,465,0000.0%0.27%
+18.8%
Q4 2020$37,295,000
+30.3%
2,465,000
+9.6%
0.22%
+13.1%
Q3 2020$28,631,000
-27.2%
2,250,000
-2.2%
0.20%
-37.1%
Q2 2020$39,330,000
+29.4%
2,300,0000.0%0.32%
+20.7%
Q1 2020$30,383,000
-18.0%
2,300,0000.0%0.26%
+4.4%
Q4 2019$37,053,000
-5.7%
2,300,000
+7.0%
0.25%
-15.8%
Q3 2019$39,302,000
+92.1%
2,150,000
+126.0%
0.30%
+123.3%
Q2 2019$20,454,000951,3260.13%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Chescapmanager LLC 1,702,110$439,1440.04%
DISCIPLINED GROWTH INVESTORS INC /MN 1,935,718$499,4150.01%
ADAR1 Capital Management, LLC 159,469$41,1430.01%
Y-Intercept (Hong Kong) Ltd 414,731$107,0010.01%
FARALLON CAPITAL MANAGEMENT LLC 1,556,251$401,5130.00%
Virtu Financial LLC 75,987$200.00%
Corsair Capital Management 19,864$5,1250.00%
WEALTH EFFECTS LLC 13,500$3,4830.00%
Cypress Capital Management LLC (WY) 5,000$1,2900.00%
Citadel Advisors 5,000$1,2900.00%
View complete list of CARA THERAPEUTICS INC shareholders